# VASOPRESSIN IN SODIUM CHLORIDE 0.9%
> **NDA217569** · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2023-09-29
## Drug
- **FDA Application Number:** NDA217569
- **Application type:** New Drug Application
- **Brand name:** VASOPRESSIN IN SODIUM CHLORIDE 0.9%
- **Generic name:** VASOPRESSIN IN 0.9% SODIUM CHLORIDE
- **Active ingredients:** VASOPRESSIN
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Corporation
- **First approval:** 2023-09-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217569)
---
*MORVS · CC0 1.0*